logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Delvys Rodríguez-Abreu

hospital universitario insular de gran canaria
H指数:57
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World First-Line Treatment Characteristics and Physician Drivers in Advanced/Metastatic Non–Small Cell Lung Cancer, PD-L1 ≥ 50%, and without Actionable Genomic Alterations

真实世界中PD-L1≥50%且无可操作基因组改变晚期/转移性非小细胞肺癌的一线治疗特征及医师驱动因素

Oncology and Therapy
IF3.2
2026-10-030
OA
Dwight H. Owen; Martin Sebastian; Hirotsugu Kenmotsu; Shilpa Viswanathan; Shivani K. Mhatre; Inderjit K. Dhillon; Cosmina Hogea; Siwen Ding; Cameron Forshaw; Hollie Bailey; Delvys Rodríguez-Abreu
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial

伊沃奈司单抗联合化疗与安慰剂联合化疗在EGFR突变型晚期非小细胞肺癌患者中的疗效比较（患者既往接受EGFR酪氨酸激酶抑制剂治疗后疾病进展）（HARMONi研究）：一项多中心、随机、双盲、Ⅲ期临床试验

Lancet Oncology
IF35.9
2026-08-240
PRE
Xiuning Le; Antonio Passaro; Yuanyuan Zhao; Yan Huang; Janessa Laskin; Delvys Rodriguez-Abreu; Antonio Calles; Lyudmila Bazhenova; Giuseppe Lo Russo; Natasha B Leighl; Federico Cappuzzo; Nicolas Girard; Sanjay Popat; Wenfeng Fang; Yongzhong Luo; Wenting Li; Zhiyong He; Hui Zhao; Mingjun Li; Qibin Song
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain

肺癌幸存者中第二原发癌的发病率：按肿瘤学治疗的西班牙全国前瞻性队列研究

lancet regional health europe
IF0
2025-08-120
OA
Mariano Provencio; Manuel Cobo; Delvys Rodriguez-Abreu; Enric Carcereny; Rafael López Castro; Manuel Fernández Bruno; Reyes Bernabé; Joaquim Bosch-Barrera; Bartomeu Massutí; Alfredo Sánchez; Ana Laura Ortega; Maria Guirado; Edel del Barco; Carlos Camps; Martín Lázaro-Quintela; Manuel Dómine; María Ángeles Sala; Karla Medina; José Luís González-Larriba; Francisco Aparisi; Juana Oramas; David Aguiar; Sara Cerezo; Beatriz Losada; Alberto Ruano-Ravina; Alexandra Cantero; Aylen Vanessa Ospina-Serrano; Virginia Calvo
Biomarker landscape in advanced NSCLC: insights from a national prospective registry

晚期NSCLC中的生物标志物图谱：一项全国性前瞻性注册研究的见解

Lung Cancer
IF4.4
2025-07-280
PRE
Mariano Provencio; Manuel Cobo; Delvys Rodriguez-Abreu; Enric Carcereny; Virginia Calvo; Rafael López Castro; Reyes Bernabé; Manuel Fernandez Bruno; Joaquim Bosch-Barrera; Edel del Barco; Karla Medina; Alfredo Sanchez-Hernandez; Guillermo Suay; Ana Laura Ortega; Sergio Vázquez; Martin Lazaro-Quintela; Maria Guirado; Anna Estival; Mariola Blanco; Alexandra Cantero; Bartomeu Massutí
Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer

接受帕博利珠单抗联合化疗作为非小细胞肺癌一线治疗的患者中，肿瘤应答和应答持续时间对生存的影响

Oncology and Therapy
IF3.2
2025-06-110
OA
Marina C. Garassino; Ying Cheng; Delvys Rodriguez-Abreu; Silvia Novello; Julien Mazieres; Andrew G. Robinson; Steven F. Powell; Balazs Halmos; Jhanelle E. Gray; Meihua Wang; Cong Chen; Jing Yang; Fabricio Souza; Paul Schwarzenberger; Luis Paz-Ares
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti–PD-(L)1 Plus Platinum Chemotherapy

LEAP-008: Lenvatinib联合Pembrolizumab治疗既往接受过抗PD-(L)1联合铂类化疗后进展的转移性NSCLC

Journal of Thoracic Oncology
IF20.8
2025-06-030
PREAI
Natasha B. Leighl; Luis Paz-Ares; Delvys Rodriguez Abreu; Rina Hui; Sofia Baka; Frédéric Bigot; Makoto Nishio; Alexey Smolin; Samreen Ahmed; Adam J. Schoenfeld; Sameh Daher; Diego L. Cortinovis; Vincenzo Di Noia; Helena Linardou; Justin F. Gainor; Corina Dutcus; Chinyere E. Okpara; Xuan Deng; Debra Kush; Ashwini Arunachalam; Andrew Song; Byoung Chul Cho
Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer: Phase 3 LEAP-006 Study

仑伐替尼联合帕博利珠单抗、培美曲塞和铂类药物作为转移性非鳞状非小细胞肺癌的一线治疗方案：III期LEAP-006研究

Journal of Thoracic Oncology
IF20.8
2025-05-240
PREAI
Roy S. Herbst; Byoung Chul Cho; Caicun Zhou; Mauricio Burotto; Manuel Cobo Dols; Mehmet A.N. Sendur; Vladimir Moiseyenko; Ignacio Casarini; Makoto Nishio; Rina Hui; Elvire Pons-Tostivint; Julia Dudnik; Samreen Ahmed; Chinyere E. Okpara; Corina Dutcus; Lina Yin; Yiwen Luo; Diana Chirovsky; Niyati Bhagwati; Delvys Rodriguez Abreu
Long-Term Effects of Ozone Treatment in Patients with Persistent Numbness and Tingling Secondary to Chemotherapy-Induced Peripheral Neuropathy. A Retrospective Study

臭氧治疗对化疗诱导性周围神经病变所致持续性麻木和刺痛的长期效果。一项回顾性研究

INTEGRATIVE CANCER THERAPIES
IF2.8
2025-01-110
OA
Bernardino Clavo; Delvys Rodríguez-Abreu; Saray Galván-Ruiz; Mario Federico; Angeles Cánovas-Molina; Yolanda Ramallo-Fariña; Carla Antonilli; Gretel Benítez; Himar Fabelo; Carla García-Lourve; Damián González-Beltrán; Ignacio J. Jorge; Francisco Rodríguez-Esparragón; Gustavo M. Callico
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry
ARCHIVOS DE BRONCONEUMOLOGIA
IF9.2
2024-10-010
OAAI
Candal-Pedreira, Cristina; Ruano-Ravina, Alberto; Calvo de Juan, Virginia; Cobo, Manuel; Cantero, Alexandra; Rodriguez-Abreu, Delvys; Estival, Anna; Carcereny, Enric; Hernandez, Ainhoa; Lopez Castro, Rafael; Medina, Andrea; Garcia Campelo, Rosario; Fernandez Bruno, Manuel; Barnabe, Reyes; Bosch-Barrera, Joaquim; Massuti, Bartomeu; Domine, Manuel; Camps, Carlos; Laura Ortega, Ana; Provencio, Mariano
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

在早期非小细胞肺癌患者中，新辅助派姆单抗加化疗后辅助派姆单抗与单独新辅助化疗的比较 (KEYNOTE-671): 一项随机，双盲，安慰剂对照的3期试验

LANCET
IF88.5
2024-09-014
PRE
Spicer, Jonathan D.; Garassino, Marina C.; Wakelee, Heather; Liberman, Moishe; Kato, Terufumi; Tsuboi, Masahiro; Lee, Se-Hoon; Chen, Ke-Neng; Dooms, Christophe; Majem, Margarita; Eigendorff, Ekkehard; Martinengo, Gaston L.; Bylicki, Olivier; Rodriguez-Abreu, Delvys; Chaft, Jamie E.; Novello, Silvia; Yang, Jing; Arunachalam, Ashwini; Keller, Steven M.; Samkari, Ayman; Gao, Shugeng
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-09-010
PRE
Felip, Enriqueta; Metro, Giulio; Soo, Ross A.; Wolf, Juergen; Solomon, Benjamin J.; Tan, Daniel S. W.; Ardizzoni, Andrea; Lee, Dae Ho; Sequist, Lecia V.; Barlesi, Fabrice; Ponce-Aix, Santiago; Abreu, Delvys Rodriguez; Campelo, Maria Rosario Garcia; Sprauten, Mette; Djentuh, Leslie O'Sullivan; Smith, Nathalie; Jary, Aline; Belli, Riccardo; Glaser, Sabine; Zou, Mike; Cui, Xiaoming; Giovannini, Monica; Yang, James Chih-Hsin
Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) plus chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Bar, Jair; Esteban, Emilio; Rodriguez-Abreu, Delvys; Ponce-Aix, Santiago; Szalai, Zsuzsanna; Felip, Enriqueta; Gottfried, Maya; Pulla, Mariano Provencio; Robinson, Andrew; Fulop, Andrea; Rao, Suman Bannur; Camidge, D. Ross; Speranza, Giovanna; Hunkapiller, Nathan; McDaniel, Robert; Jung, Byoungsok; Burkhardt, David; Mauntz, Ruth; Chen, Cai; Pena, Carol; Cristescu, Razvan; Dettman, Elisha J.; Townson, Steven M.; Kobie, Julie; Csoszi, Tibor
Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC)
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Rodriguez-Abreu, Delvys; Hochmair, Maximillian; Cho, Byoung Chul; Csoszi, Tibor; Kutiel, Talia Shentzer; Mueller, Veronika; Ahn, Myung-Ju; Kowalski, Dariusz; Maio, Michele; Moiseyenko, Vladimir; Navarro, Alejandro; Niu, Jianxin; Fung, Andrea S.; Lips, Carolin; Zhou, Heng; Zhao, Bin; Lara-Guerra, Humberto; Peled, Nir
Impact of fecal microbiome on the efficacy of neoadjuvant chemo-immunotherapy and colitis adverse events: Findings from the NADIM II Trial
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Serna-Blasco, Roberto; Festa, Alejandro Rodriguez; Sanz-Moreno, Sandra; de Lope, Lucia Robado; Medel, Pilar Mediavilla; Nadal, Ernest; Larriba, Jose Luis Gonzalez; Martinez-Marti, Alex; Bernabe, Reyes; Bosch-Barrera, Joaquim; Casal-Rubio, Joaquin; Calvo, Virginia; Insa, Amelia; Ponce, Santiago; Reguart, Noemi; de Castro, Javier; Mosquera, Joaquin; Cobo, Manuel; Aguilar, Andres; Camps, Carlos; de Castro, Rafael Lopez; Moran, Teresa; Barneto, Isidoro; Rodriguez-Abreu, Delvys; de la Rosa, Carlos Aguado; Palmero, Ramon; Hernando-Trancho, Florentino; Martin-Lopez, Javier; Cruz-Bermudez, Alberto; Massuti, Bartomeu; Vila, Miguel Angel Molina; Romero, Atocha; Provencio, Mariano

研究方向

暂未获取到该数据
M
Mariano Provencio
H 指数:73论文数:1,036被引数:2.8万
M
Manuel Cobo
H 指数:57论文数:524被引数:2.8万
R
Rafael López Castro
H 指数:21论文数:224被引数:2,342
E
Enric Carcereny
H 指数:43论文数:412被引数:2.1万
J
Joaquim Bosch‐Barrera
H 指数:38论文数:253被引数:5,762
E
Enriqueta Felip
H 指数:129论文数:1,499被引数:11.1万
E
E. del Barco
H 指数:23论文数:195被引数:2,518
A
Ana Laura Ortega Granados
H 指数:29论文数:223被引数:3,726
R
Reyes Bernabé
H 指数:34论文数:200被引数:1.2万
Ó
Óscar Juan
H 指数:39论文数:397被引数:8,683